Drug duo aims to tackle high blood pressure in obesity
Disease control
Not yet recruiting
This study tests whether combining two medications, empagliflozin and finerenone, can lower blood pressure in adults with obesity and stage 1 hypertension. Participants take the drugs or a placebo daily for 12 weeks. The trial also measures effects on kidney function, inflammatio…
Phase: NA • Sponsor: Heart Health Research Center • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC